SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-000676
Filing Date
2018-02-07
Accepted
2018-02-07 16:56:08
Documents
59
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipix_10q.htm 10-Q 426321
2 CERTIFICATION ipix_ex311.htm EX-31.1 7997
3 CERTIFICATION ipix_ex312.htm EX-31.2 8071
4 CERTIFICATION ipix_ex321.htm EX-32.1 2854
5 CERTIFICATION ipix_ex322.htm EX-32.2 2965
  Complete submission text file 0001477932-18-000676.txt   3204000

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipix-20171231.xml EX-101.INS 572351
7 XBRL TAXONOMY EXTENSION SCHEMA ipix-20171231.xsd EX-101.SCH 62913
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20171231_cal.xml EX-101.CAL 44756
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20171231_def.xml EX-101.DEF 176051
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20171231_lab.xml EX-101.LAB 257157
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20171231_pre.xml EX-101.PRE 232304
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37357 | Film No.: 18581750
SIC: 2834 Pharmaceutical Preparations